KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Supernus Pharmaceuticals (SUPN) Income from Continuing Operations (2016 - 2025)

Supernus Pharmaceuticals (SUPN) has disclosed Income from Continuing Operations for 15 consecutive years, with 4105000.0 as the latest value for Q4 2025.

  • Quarterly Income from Continuing Operations fell 126.7% to 4105000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 38580000.0 through Dec 2025, down 152.18% year-over-year, with the annual reading at 38550000.0 for FY2025, 152.19% down from the prior year.
  • Income from Continuing Operations for Q4 2025 was 4105000.0 at Supernus Pharmaceuticals, up from 45117000.0 in the prior quarter.
  • The five-year high for Income from Continuing Operations was 38497000.0 in Q3 2024, with the low at 45117000.0 in Q3 2025.
  • Average Income from Continuing Operations over 5 years is 7538850.0, with a median of 6779500.0 recorded in 2021.
  • The sharpest move saw Income from Continuing Operations skyrocketed 2508.22% in 2024, then plummeted 8370.63% in 2025.
  • Over 5 years, Income from Continuing Operations stood at 2442000.0 in 2021, then soared by 943.45% to 25481000.0 in 2022, then plummeted by 95.54% to 1137000.0 in 2023, then surged by 1252.42% to 15377000.0 in 2024, then plummeted by 126.7% to 4105000.0 in 2025.
  • According to Business Quant data, Income from Continuing Operations over the past three periods came in at 4105000.0, 45117000.0, and 22469000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.